The FDA has granted Medtronic approval for its MiniMed 530G with Enlite system, which the company said is the first artificial pancreas device that stops insulin delivery automatically when the patient's blood sugar falls to preset levels. The device, designed for diabetes patients 16 years or older, will be available commercially in the next few weeks.

Related Summaries